VALANX Biotech and FinaBio sign joint licensing agreement to commercialise ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines.
Berry Global has launched a new easy-squeeze ophthalmic 10ml bottle that has been qualified for use with Aptar Pharma’s globally recognised Ophthalmic Squeeze Dispenser (OSD).
This week’s budget saw several major announcements for the UK life sciences sector. Yogan Patel, head of life sciences for MHA, the UK member firm of the global Baker Tilly network, explores what’s been announced and what it means for the industry.
Sterling Pharma Solutions, announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity.
ProductLife Group (PLG) announced the acquisition of Callisto, a UK-based consultancy specialising in Regulatory Affairs (RA), Pharmacovigilance (PV) and GMDP services within multiple regulated sectors.
Ardena announced a expansion of its bioanalytical services in the Netherlands, including a new bioanalytical lab at Ardena’s Pivot Park facility in Oss and new GLP capabilities in Assen.
Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.
Naobios and Sumagen Canada Inc, a Korean-Canadian biotechnology company developing an HIV-1 vaccine candidate, announced the production of the HIV-1 vaccine candidate at bench scale.
AstraZeneca’s drug Fasenra (benralizumab) has been approved in the European Union as an additional treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA).
CluePoints announced that Richard Young has been appointed as its new chief strategy officer who will ensure CluePoints’ continued growth and development as a provider of integrated data review software.
